Little at a time: trying to understand the battery of benefits of sodium-glucose contransporter 2 inhibitors in heart failure
Eur J Heart Fail
.
2023 Feb;25(2):235-237.
doi: 10.1002/ejhf.2766.
Epub 2023 Jan 16.
Authors
Stephan von Haehling
1
2
,
Ryosuke Sato
1
,
Javed Butler
3
4
,
Stefan D Anker
5
6
Affiliations
1
Department of Cardiology and Pneumology, University of Göttingen Medical Center, Göttingen, Germany.
2
German Center for Cardiovascular Research (DZHK), partner site Göttingen, Göttingen, Germany.
3
Baylor Scott and White Research Institute, Dallas, TX, USA.
4
University of Mississippi, Jackson, MS, USA.
5
Department of Cardiology (CVK), Berlin Institute of Health Center for Regenerative Therapies (BCRT), Berlin, Germany.
6
German Centre for Cardiovascular Research (DZHK) partner site Berlin, Charité Universitätsmedizin, Berlin, Germany.
PMID:
36597825
DOI:
10.1002/ejhf.2766
No abstract available
Publication types
Editorial
Comment
MeSH terms
Diabetes Mellitus, Type 2*
Glucose
Heart Failure*
Humans
Hypoglycemic Agents
Sodium
Substances
Glucose
Sodium
Hypoglycemic Agents